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Purpose: Deposition of polymeric IgA1 in the kidney mesangium is the hallmark 
of IgA nephropathy, but the molecular mechanisms of IgA-mediated mesangial re-
sponses and inflammatory injuries remain poorly understood. We hypothesize that 
Toll-like receptor 4 (TLR4) is involved in IgA-induced mesangial cell activation. 
Materials and Methods: Mouse mesangial cells were stimulated with lipopoly-
saccharide (LPS) (1 μg/mL), IgA (20 μg/mL), or both, and TLR4 expression was 
measured by real time RT-PCR and Western blot. Intracellular responses to LPS or 
IgA were assessed by Western blot for ERK1/2, JNK, p38 MAP kinases (MAPKs), 
Iκ-Bα degradation and fibronectin secretion. MCP-1 secretion was assessed by 
ELISA. Small interfering RNA (siRNA) of TLR4 was used to confirm that the ef-
fects were caused by TLR4 activity. Results: LPS- or IgA-treatment upregulated 
the levels of TLR4 mRNA and protein in cultured MMC at 24 h. LPS and IgA in-
duced rapid phosphorylation of MAPKs, but degradation of Iκ-Bα was observed 
only in LPS-treated MMC. LPS, but not IgA, induced increased secretion of 
MCP-1 and fibronectin at 24 h or 48 h. Combined LPS and IgA treatment did not 
cause additional increases in TLR4 mRNA and protein levels or Iκ-Bα degrada-
tion, and MCP-1 and fibronectin secretions were less than with LPS alone. LPS- 
or IgA-induced TLR4 protein levels and MAPK activation were inhibited by 
transfection with TLR4 siRNA. Conclusion: These results indicate that the activa-
tion of MAPKs and MCP-1 secretion are mediated by TLR4, at least in part, in 
IgA-treated mesangial cells. TLR4 is involved in mesangial cell injury by induc-
tion of pro-inflammatory cytokines in IgA nephropathy.
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INTRODUCTION
Toll-like receptors (TLRs) are a family of pathogen pattern recognition receptors 
that activate defense mechanisms in response to exposure to various bacteria and vi-
ruses. Research in this field has rapidly expanded since the first discovery of TLR4 
in 1997, with 11 currently recognized subtypes in humans and 13 in mice.1,2 TLRs 
may respond to endogenous substances produced during tissue injury without exog-
enous stimuli, and they may not always be as protective as in native immunity. Vari-
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in Dulbecco’s modified Eagle’s medium (DMEM) (Invitro-
gen, Gaithersburg, MD, USA) containing 5% fetal bovine 
serum (Invitrogen). MMC were maintained and incubated 
at 37°C in humidified 5% CO2 in air. Nearly confluent MMC 
were incubated in serum-free media for 16 h to arrest and 
synchronize cell growth. MMC were stimulated with LPS 
(Sigma, Poole, UK), IgA (Sigma, I2636, human secretory 
IgA, 400 kDa), or both for up to 48 h. Doses of 1 μg/mL for 
LPS and 20 μg/mL for IgA were chosen for the experiment 
after serial dose testing from 10 ng/mL to 10 μg/mL for LPS 
and 10 μg/mL to 200 μg/mL for IgA. Cell viability was not 
significantly altered in the doses chosen for experiments, 
which was confirmed by the trypan blue exclusion test. Cells 
were pre-treated with inhibitors of ERK, JNK, and p38 MAP 
kinases (MAPKs) (Calbiochem, San Diego, CA, USA; 10 
μM each) for 60 min prior to LPS or IgA stimulation.
RNA isolation and real-time RT-PCR 
Total RNA was extracted from cultured MMC by Trizol 
(Invitrogen) extraction, and 4 μg of isolated RNA were re-
verse-transcribed into cDNA using a high-capacity cDNA 
synthesis kit (iNtRON biotechnology, Seoul, Korea). Real-
time PCR was performed with the ABI 7000 sequence de-
tection system (Applied Biosystems, Foster City, CA, USA) 
using SYBR Green PCR Master Mix (Applied Biosystems) 
in accordance with the manufacturer’s instructions. PCR 
cycling conditions included pre-denaturing at 95°C for 15 s, 
then 35 cycles of denaturation at 95°C for 5 s, and combined 
annealing/extension at 61°C for 30 s. Semilog amplification 
curves were evaluated using the comparative quantification 
method (2-ΔΔCt), and GAPDH was used for normalization 
of all reported gene expression levels. The primer sequenc-
es used in the present study were as follows: TLR4: for-
ward CATTCAAGACCAAGCCTTTCAG and reverse 
CCAGGTTTTGAAGGCAAGTTTT. GAPDH: forward 
TGCACCACCAACTGCTTAG and reverse GGATGC 
AGGGATGATGTTC.
Western blot 
Harvested MMC were lysed in sodium dodecyl sulfate (SDS) 
sample buffer [2% SDS, 10 mM Tris-HCl, pH 6.8, 10% 
(vol/vol) glycerol]. The samples were treated with Laemmli 
sample buffer, heated at 100°C for 5 min, and electropho-
resed in a 10% acrylamide denaturing SDS-polyacrylamide 
gel. Proteins were then transferred to a Hybond-ECL mem-
brane using a Hoeffer semidry blotting apparatus (Hoeffer 
Instruments, San Francisco, CA, USA), and the membrane 
ous TLRs are distributed in different cell types either consti-
tutively or in response to various conditions. In the kidney, 
TLR4 and probably TLR11 help to recognize some strains 
of uropathogenic bacteria in urothelial cells.3 Other known 
relationships include TLR2 and TLR4 in ischemia/reperfu-
sion injury of renal tubular epithelial cells, TLR4 in renal al-
lograft rejection, and TLR3, TLR7 and TLR9 in immune 
complex-mediated glomerulonephritides.4
IgA nephropathy (IgAN) is one of the most common 
forms of glomerulonephritis worldwide, and is character-
ized by mesangial expansion, mesangial proliferation, and 
predominant deposition of IgA in the mesangium. IgA de-
posited in the mesangium is deemed mainly responsible for 
functional derangement and histologic alteration. The mo-
lecular mechanisms of IgA-mediated mesangial responses 
and the initiation of inflammatory injury remain poorly un-
derstood. There has been circumstantial but supportive evi-
dence for the involvement of TLRs in the glomerular injury 
of IgAN. First, tonsillar mononuclear cells of IgAN patients 
produce higher amounts of monocyte chemoattractant pro-
tein-1 (MCP-1) and interleukin (IL)-8 than tonsils from non-
IgAN patients when incubated with staphylococcus entero-
toxin-B or lipopolysaccharide (LPS).5 Upregulation of TLR4 
expression in circulating mononuclear cells of IgAN pa-
tients is associated with proteinuria and heavy microscopic 
hematuria of IgAN patients.6 Second, glomerular mesangial 
cells express TLR1-4 and TLR6,7 and may promote CXC 
cytokines upon TLR4 activation.8 Third, levels of some en-
dogenous TLR4 ligands such as fibronectin and fibrinogen 
increase in the blood or are frequently co-deposited in the 
glomerular mesangium of IgAN.9 Fourth, TLR4 and TLR9 
expression increases in renal extracts of post-transplant 
IgAN patients.10 TLR9 polymorphisms are associated with 
disease severity in patients with IgAN.11 Nonetheless, there is 
no direct evidence for TLR involvement in mesangial cell 
activation in IgAN. In this study, we explored TLR4 involve-
ment in IgA-stimulated mesangial cell activation and evalu-
ated whether LPS caused additive or synergistic effects in 
IgA-induced mesangial cell activation.
MATERIALS AND METHODS
　　　
Cell culture
Mouse mesangial cells (MMC) from an SV40 transgenic 
mouse (MES-13) were purchased from the American Type 
Culture Collection (Manassas, VA, USA) and maintained 
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Tween-20. Next, the membrane was incubated with horse-
radish peroxidase-linked goat anti-rabbit IgG (Santa Cruz 
Biotechnology). The washes were repeated, and the mem-
brane was developed with a chemiluminescent agent (ECL; 
Amersham Life Science Inc., Arlington Heights, IL, USA). 
Proteins were quantified using a densitometer.
Enzyme-linked immunosorbent assay 
The levels of MCP-1 secreted into the culture media under 
different experimental conditions were determined using a 
commercial MCP-1 ELISA kit (R&D Systems, Abingdon, 
UK), sensitive to 2 pg/mL, according to the manufacturer’s 
protocol. 
siRNA transfection 
Pre-designed mouse TLR4 siRNA was purchased from Am-
bion (Austin, TX, USA). TLR4 siRNA 25nM was transfect-
ed using the lipofectamine method (Invitrogen) for 6 hours. 
Media were then replaced with fresh serum-free media con-
taining 10 μg/mL LPS or 20 μg/mL IgA, and the cells were 
incubated for up to 24 h.
Statistical analysis
Results are expressed as the mean±standard error (SEM) of 
experiments conducted more than three times. Statistical 
comparisons were evaluated using the Mann-Whitney U test. 
Differences were deemed significant if p<0.05.
 
RESULTS
 
LPS increased TLR4 mRNA levels 3.5-fold at 12 h and 3.2-
fold at 24 h in MMC. TLR4 protein levels increased 2-fold 
by 24 h and slightly more by 48 h. IgA upregulated the level 
of TLR4 mRNA by 3-fold at 24 h, and the level of proteins 
3.6- and 1.5b-fold at 24 h and 48 h, respectively. When MMC 
were stimulated with LPS and IgA together, there was no ad-
ditive increase in TLR4 mRNA and protein expression at 24 
h. At 12 h, the effect of LPS on TLR4 mRNA was even ab-
rogated by IgA cotreatment to the level of IgA alone (Figs. 
1 and 2).
LPS induced phosphorylation of ERK1/2, JNK, and p38, 
and degradation of Iκ-Bα at 5 min, but pre-treatment with 
inhibitors of ERK1/2, JNK, and p38 inhibited these reac-
tions. IgA and combined IgA and LPS treatment also in-
duced rapid phosphorylation of ERK1/2, JNK, and p38 
MAPKs at 5 min (Fig. 3). Iκ-Bα degradation was observed 
was incubated in blocking buffer (1×TBS, 0.1% Tween-20, 
and 5% nonfat milk) for 1 h at room temperature, followed 
by an overnight incubation at 4°C in a 1:1000 dilution of 
antibodies to p-ERK, p-JNK, p-p38, Iκ-Bα (Cell Signaling 
Technology, Danvers, MA, USA), fibronectin (Dako, Car-
pinteria, CA, USA), or β-actin (Santa Cruz Biotechnology 
Inc., Santa Cruz, CA, USA). The membrane was then washed 
once for 15 min and twice for 5 min in 1×TBS with 0.1% 
Fig. 1. TLR4 mRNA level was upregulated by LPS at 12 hours and 24 hours, 
and by IgA at 24 hours. Combined LPS and IgA stimulation did not increase 
the TLR4 mRNA level. *p<0.05 vs. 24 hours control, †p<0.05 vs. 12 hours con-
trol, ‡p<0.05 vs. 12 hours LPS. TLR4, Toll-like receptor 4; mRNA, messenger 
ribonucleic acid; LPS, lipopolysaccharide.
Fig. 2. TLR4 protein expression was increased by LPS or IgA stimulation at 
24 hours and 48 hours. However, combined stimulation of LPS and IgA did 
not show an additive effect. *p<0.05 vs. 48 hours control, †p<0.05 vs. 24 
hours control. TLR4, Toll-like receptor 4; mRNA, messenger ribonucleic 
acid; LPS, lipopolysaccharide.
Fig. 3. LPS, IgA, and combined LPS and IgA treatment induced rapid phos-
phorylation of ERK1/2, JNK, and p38 MAPKs at 5 minutes. LPS, lipopolysac-
charide; MAPKS, MAP kinases.
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at 60 min in LPS-treated MMC, but not in IgA- and com-
bined LPS and IgA-treated MMC (Fig. 4). 
MCP-1 secretion in the culture media increased 1.2-fold 
at 48 h in LPS-treated MMC. IgA treatment caused an in-
crease MCP-1 secretion at 6 h, but this decreased by 48 h. 
MCP-1 secretion at 48 h was significantly lower after com-
bined LPS and IgA treatment than after LPS or IgA treat-
ment alone (Fig. 5). Fibronectin secretion increased 1.7- 
and 1.6-fold at 24 h and 48 h, respectively, in LPS-treated 
MMC. IgA- and Combined IgA and LPS-treated MMC 
displayed less fibronectin secretion than MMC treated with 
LPS alone (Fig. 6). 
LPS- or IgA-induced mesangial cellular TLR4 expres-
sion and MAPK activation were all inhibited by transfec-
tion with TLR4 siRNA (Fig. 7).
DISCUSSION
Although progress has been made in understanding the struc-
Fig. 4. Iκ-Bα degradation was observed at 60 minutes in LPS-treated MMC, 
but not in IgA- and combined LPS and IgA-treated MMC. *p<0.05 vs. con-
trol. LPS, lipopolysaccharide; MMC, mouse mesangial cells.
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tural abnormalities of IgA molecules in IgAN,12 the molecu-
lar mechanisms behind mesangial activation by IgA remain 
poorly understood. Since infections can trigger symptoms 
and raise serum IgA levels in IgAN patients, we hypothe-
sized that TLR4 may be involved in IgA-induced mesangial 
activation. In this study, cultured MMC showed elevated 
TLR4 mRNA and protein levels when stimulated with IgA. 
TLR4 protein production was observed at 48 h, while TLR4 
mRNA was elevated from 24 h, probably due to transcrip-
tional effects.
TLR4 is expressed under basal culture conditions in MMC 
and distal tubular cells.7 Upregulation of TLR4 expression 
by angiotensin II has been reported in mouse mesangial 
cells.13 Our results demonstrate that IgA is another agonist 
of TLR4 expression in mesangial cells, although the mech-
anism is still unclear. Cytokines produced by activated me-
sangial cells in response to IgA binding may promote TLR4 
expression in mesangial cells. Patole, et al.7 reported, how-
ever, that interferon (IFN)-γ and tumor necrosis factor-α 
Fig. 7. LPS- or IgA-induced TLR4 protein expression and MAPK activation 
were inhibited by transfection with TLR4 siRNA. LPS, lipopolysaccharide; 
TLR4, Toll-like receptor 4; MAPK, MAP kinase; siRNA, small interfering ri-
bonucleic acid.
Fig. 5. MCP-1 secretion in the culture media increased at 48 hours in LPS-
treated MMC, but was significantly lower after treatment with combined 
LPS and IgA compared to LPS alone. *p<0.05 vs. 48 hours control, †p<0.05 
vs. 48 hours LPS, ‡p<0.05 vs. 48 hours IgA. LPS, lipopolysaccharide; MMC, 
mouse mesangial cells.
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hours in LPS-treated MMC, but did not increase after treatment with IgA 
alone or combined LPS and IgA. *p<0.05 vs. 24 hours control, †p<0.05 vs. 48 
hours control. LPS, lipopolysaccharide; MMC, mouse mesangial cells.
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upregulate levels of TLR2, TLR3, and TLR6 mRNA, but 
not of TLR4 mRNA, in mesangial cells. Alternatively, IgA 
binding may upregulate mesangial TLR4 expression by in-
creasing endogeneous ligands for TLR4. We assessed fibro-
nectin production, but it did not increase following IgA treat-
ment. TLR ligation did not lead clearly to either protection or 
aggravation. Induction of heat shock protein (HSP) 70 is pro-
tective against oxidative injury in mesangial cells,14 whereas 
increased tubular expression of HSP70 is an indicator of 
cyclosporine nephrotoxicity.15 Since there are other endoge-
nous ligands and agonists for TLR4 that were not tested in 
this study, this possibility is still open.
In the TLR4 signaling pathway, MAPK and NFκB acti-
vation follows TLR4 activation. We observed MAPK acti-
vation in IgA-stimulated MMC, but Iκ-Bα degradation did 
not occur. The interaction of IgA with Fcα receptors of hu-
man mesangial cells can activate NFκB and induce expres-
sion and synthesis of MCP-1, IL-8, and IFN-inducible pro-
tein 10.16 Expression of MCP-1 and osteopontin can be 
induced by LPS via the TLR4 signaling pathway in mesan-
gial cells of lupus-prone mice.17 The fact that Iκ-Bα degra-
dation and MCP-1 production were only observed after 
LPS treatment makes it likely that MCP-1 production oc-
curred via the TLR4-MAPK-NF-κB pathway. Neither NF-
κB activation nor persistent MCP-1 production by MMC 
stimulated by IgA indicates that IgA per se does not have 
strong proinflammatory activity in this situation.
Initially, we expected additive or synergistic effects of LPS 
treatment in IgA-stimulated mesangial cells. We found, how-
ever, that IgA treatment did not change the effect of LPS 
treatment, and sometimes even abolished it. The reasons 
behind the differing effects of the combined treatment are 
not clear. The possibility that LPS and IgA compete for the 
same receptor is unlikely, since IgA is known to bind spe-
cifically to the mesangial transferrin receptor and LPS rec-
ognizes TLR4. Exposure to both IgA and LPS may switch 
on protective mechanisms in mesangial cells. Human se-
rum IgA has both pro-inflammatory and anti-inflammatory 
properties in LPS-stimulated monocytes and peripheral 
blood mononuclear cells.18,19 Shimosawa, et al.20 reported 
that mesangial TLR4 expression decreased after LPS admin-
istration in a high IgA strain of ddY mice, while mesangial 
proliferation, macrophage infiltration, and MCP-1 mRNA 
expression increased. The modified mesangial responses to 
LPS and IgA observed in our study might contribute to the 
feedback mechanisms maintaining a balance between pro-
inflammatory and anti-inflammatory activities.
Our study design has some drawbacks in its attempt to 
simulate human IgAN. We used unaltered IgA instead of 
macromolecular IgA, which is known as the major patho-
genic molecule in IgA nephropathy in vivo. Our data showed, 
however, that MMC could respond to unaltered IgA mole-
cules as well. It is unclear whether we would have observed 
higher responses to aggregated or chemically modified IgA. 
In vivo, mesangial injury may be governed or potentiated 
by infiltrating intraglomerular inflammatory cells rather 
than IgA. An association between urinary dysfunction and 
TLR4 upregulation in circulating mononuclear cells supports 
the idea that inflammatory cells play a role in IgAN patients.6 
In IgAN, intraglomerular mononuclear cells are associated 
with proteinuria.21 Intraglomerular inflammatory cells could 
express TLR7 and TLR9, and TLR9 stimulation with CpG 
DNA causes Th1 polarization and disease exacerbation in 
ddY mice.11
In conclusion, the activation of MAPKs and secretion of 
MCP-1 is mediated, at least in part, by TLR4 in IgA-treated 
mesangial cells. TLR4 seems to be involved in mesangial 
cell injury by the induction of pro-inflammatory cytokines 
in IgA nephropathy. More studies are needed to understand 
the intraglomerular cross-talk between mesangial and in-
flammatory cells.
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